Naari Pharma India Overview
- Founded
-
1978

- Status
-
Acquired/Merged
- Employees
-
219

- Latest Deal Type
-
PE Growth
- Financing Rounds
-
4
- Investments
-
2
Naari Pharma India General Information
Description
Manufacturer of steroid and hormone drugs for the female health segment. The company manufactures and distributes active pharmaceutical ingredients and finished formulations with a special emphasis on high active female hormones.
Contact Information
Website
www.naari.co
Formerly Known As
Indo Phyto Chemicals
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Parent Company
Tenshi Life Sciences
Primary Office
- 210 A, ShahpurJat
- New Delhi, 110049
- India
+91 011 0000 0000
Naari Pharma India Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Naari Pharma India Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Prithi Kochhar | Co-Founder, Chief Executive Officer & Board Member | ||
Amanda Red | CEO | ||
Hermann Osterwald | Co-Founder & Chairman | ||
Alex Sollerio | Co-Founder |
Naari Pharma India Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
0000000000 0000000 | Naari Pharma India | Board Member | 000 0000 |
0000000 000000000 | Naari Pharma India | Co-Founder & Chairman | 000 0000 |
00000000 0000000 | Naari Pharma India | Board Member | 000 0000 |
000000 00000000000 | Naari Pharma India | Board Member | 000 0000 |
000000 00000 | Naari Pharma India | Board Member | 000 0000 |
Naari Pharma India Signals
Naari Pharma India Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Naari Pharma India Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000 0000000 | 12-Jun-2020 | 0000000000 | Buildings and Property | 000000 00 | |
OC Pharm (Three ANDAs) | 01-Jan-2019 | Corporate Asset Purchase | Buildings and Property | 000000 00 |